The Society for the Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to professionals working in the field of cancer immunology and immunotherapy. A number of UPCI investigators are active members of this research community, and Lisa Butterfield, PhD, Professor of Medicine, Surgery, and Immunology and Director of UPCI’s Immunologic Monitoring and Cellular Products Laboratory, currently serves in a prominent leadership role as SITC’s Vice President.
Watch the video to learn more about this team of scientists and the evolution of cancer immunotherapy over the past 30 years.
